Syno Capital
Justin Xiang is an experienced professional who currently holds various advisory and leadership roles in the healthcare, biotech, and investment industries. Justin is currently a member of the International Advisory Council at Massachusetts General Hospital, a Chief Investment Officer and Co-Founder at Syno Capital, a Senior Advisor at ZhongAn Insurance, and the Chief Scientific Officer at New Legacy. Additionally, Justin previously served as the Chairman and President at ZhongAn Life Sciences, a Senior Scientist at Schrödinger, and a Research Assistant at Genentech. Justin holds a PhD in Computational and Molecular Biophysics from Washington University in St. Louis, where Justin also completed their Bachelor's degree in Biomedical Engineering, Economics, Mathematics, and Computer Science.
This person is not in any teams
Syno Capital
Founded in 2015, Syno Capital is a global investment firm focused on developing breakthrough innovations to meet our healthcare challenges. With our presence in New York, Hong Kong and Shanghai, we want to work with the greatest minds no matter where they are to solve the toughest problems.